Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 270.000 - Blood Screening Of Newborns For Treatable Diseases And Disorders
Section 270.011 - Confidentiality of Newborn Screening Test Results and Information
Current through Register 1531, September 27, 2024
(A) The Newborn Blood Screening Program shall maintain the confidentiality of testing results generated by the Program and information submitted to the Program for purposes of newborn screening and follow-up of newborn testing.
(B) Other than as required for routine notification of newborn blood testing as described in 105 CMR 270.009, the Newborn Blood Screening Program shall not disclose newborn screening results or any information or patient identifiers which because of name, identifying number, mark or description can be readily associated with a particular individual or the individual's parents/guardians, or any newborn screening information that could be used in combination with other information to identify an individual, except to:
(C) The Newborn Screening Program may provide a Limited Data Set, as defined in the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (45 CFR §164.514(e)), of newborn screening results or information to researchers upon approval from the Department and subject to the terms of a written data use agreement.
(D) All individually identifiable testing results and information, as defined by the Department, shall be considered confidential and shall not be available as a public record under M.G.L. c. 66.